HDHanife Salih Doğan

Hanife Salih Doğan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hanife Salih Doğan has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Recombinant depolymerase DP21 from Klebsiella phage GADU21 exerts Dual-Antibiofilm and biofilm-disrupting activity against multiple bacterial species

    by Hanife Salih Doğan, Gülistan Asya Orbayoğlu, Abdulkerim Karaynir, Sahd Ali, Yunus Doğan, Melis Yalçin, Tuğrul Hoşbul, Bülent Bozdoğan

  • Moleküler Biyolojide Çağdaş Yaklaşımlar: Kuramdan Uygulamaya

    by Belemir Gülhan, Levent Tümkaya, Betül Bayraktar, Salih Sarıcaoğlu, Büşra Sevgi, Kübra Sevgi, Sema Leblebici, Ece Avuloğlu Yılmaz, Emine Çelikoğlu, Ergin Kariptaş, et al.

    Moleküler biyolojideki gelişmeler, yalnızca mevcut bilgileri derinleştirmekle kalmayıp biyolojik sistemlerin incelenmesinde yeni araştırma sorularını da gündeme getirmektedir. Moleküler Biyolojide Çağdaş Yaklaşımlar, farklı araştırma alanlarından elde edilen bilimsel birikimi bir araya getirerek moleküler mekanizmaların anlaşılmasına yönelik güncel yaklaşımları ele almaktadır. Eser, bilim insanlarına mevcut bilgileri farklı perspektiflerden değerlendirme, yöntemsel gelişmeleri izleme ve gelecekteki araştırmalara yön verebilecek bilimsel tartışmaları keşfetme olanağı sunmaktadır. Aynı zamanda hem akademisyenler ve öğrenciler hem de bilimin geleceğine yön veren moleküler dünyayı keşfetmek isteyen tüm araştırmacılar için vazgeçilmez bir rehber niteliğindedir.

  • Degradation of Preformed Gram-Positive and Gram-Negative Bacterial Biofilms Using Disintegrated and Intact Phages

    by Sahd Ali, Abdulkerim Karaynir, Hanife Salih Doğan, Ramesh Nachimuthu, Kingsley Badu, Bülent Bozdoğan

    Introduction: Biofilm is a major challenge across several sectors and contributes to serious risks to public health. This study aimed to evaluate the antibiofilm efficacy of disintegrated phages, whose lytic activities have been eliminated, against bacterial biofilms. Methods: A total of seven lytic phages were disintegrated by sonication and confirmed to have completely lost their lytic activities by the spot test. Subsequently, both the disintegrated and intact phages were tested on the biofilms produced by five different biofilm-producing bacteria. The effects of heat and proteinase K on the ability of disintegrated phages to disrupt biofilms were determined. Moreover, the structural proteins released after the disintegration of phages were screened for their presence of lipase, amylase, protease, and DNase activities. Genome analysis of all the seven phages were screened for the presence of genes encoding proteins with enzymatic activities. Results: The disintegrated phages showed more effectiveness in degrading the bacterial biofilm when compared with intact phages. The amylase test results were positive for all the seven disintegrated phages tested, confirming the presence of starch-degrading enzymes. Genomic analysis of five phages revealed the presence of genes encoding transglycosylases, amidases, and glycosaminidases, which could contribute to biofilm degradation. However, only four of these proteins were also structural proteins of phages. Conclusions: Our study demonstrated that disintegrated phages without lytic effects can still possess biofilm degrading ability, probably associated with the enzymatic activities of their structural proteins. This study showed that phages may have activities beyond lytic phage activities exhibited by their structural enzymes.


  • Biological and genomic characteristics of three novel bacteriophages and a phage-plasmid of Klebsiella pneumoniae

    by Aylin Uskudar-Guclu, Sezin Unlu, Hanife Salih-Dogan, Suleyman Yalcin, Ahmet Basustaoglu

    Bacteriophages have emerged as promising candidates for the treatment of difficult-to-treat bacterial infections. The aim of this study is to isolate and characterize phages infecting carbapenem-resistant and extended-spectrum beta-lactamase producer Klebsiella pneumoniae isolates. Water samples were taken for the isolation of bacteriophages. One-step growth curve, the optimal multiplicity of infection (MOI), thermal and pH stabilities, transmission electron microscopy and whole-genome sequencing of phages were studied. Four phages were isolated and named Klebsiella phage Kpn02, Kpn17, Kpn74, and Kpn13. The optimal MOI and latent periods of phage Kpn02, Kpn17, Kpn74, and Kpn13 were 10, 1, 0.001, and 100 PFU/CFU and 20, 10, 20, and 30 min, respectively. Burst sizes ranged from 811 to 2363. No known antibiotic resistance and virulence genes were identified. No tRNAs were detected except Klebsiella phage Kpn02 which encodes 24 tRNAs. Interestingly, Klebsiella phage Kpn74 was predicted to be a lysogenic phage whose prophage is a linear plasmid molecule with covalently closed ends. Of the Klebsiella-infecting phages presented in current study, virulent phages suggest that they may represent candidate therapeutic agents against MDR K. pneumoniae, based on short latent period, high burst sizes and no known antibiotic resistance and virulence genes in their genomes.


  • Two novel phages, Klebsiella phage GADU21 and Escherichia phage GADU22, from the urine samples of patients with urinary tract infection

    by Hanife Salih Doğan, Abdulkerim Karaynir, Ülkü İrEm Yilmaz, Bilgin Bahadır Başgöz, Tuğrul Hoşbul, Bülent Bozdoğan

    Phages are found in a wide variety of places where bacteria exist including body fluids. The aim of the present study was to isolate phages from the urine samples of patients with urinary tract infection. The 10 urine samples were cultured to isolate bacteria and also used as phage sources against the isolated bacteria. From 10 urine samples with positive cultures, 3 phages were isolated (33%) and two of them were further studied. The Klebsiella phage GADU21 and Escherichia phage GADU22 phages infected Klebsiella pneumonia and Escherichia coli, respectively. Among the tested 14 species for host range analysis, the Klebsiella phage GADU21 was able to infect two species which are Klebsiella pneumonia and Proteus mirabilis, and Escherichia phage GADU22 was able to infect four species which are Shigella flexneri, Shigella sonnei and Escherichia coli. Among different isolates of the indicator bacteria for each phage, GADU21 infected half of the tested 20 Klebsiella pneumonia isolates while GADU22 infected 85% of the tested 20 E. coli isolates. The genome sizes and GC ratios were 75,968 bp and 44.4%, and 168,023 bp and 35.3% for GADU21 and GADU22, respectively. GADU21 and GADU22 were both lytic and had no antibiotic resistance and virulence genes. GADU21 was homologue with Klebsiella phage vB_KpP_FBKp27 but only 88% of the genome was covered by this phage. The non-covered parts of the GADU21 genome included genes for tail-fiber-proteins and HNH-endonuclease. GADU22 had 94.8% homology with Escherichia phage vB_Eco_OMNI12 and had genes for immunity proteins. Phylogenetic analysis showed GADU21 and GADU22 were members of Schitoviridae family and Efbeekayvirus genus and Straboviridae family and Tevenvirinae genus, respectively. VIRIDIC analysis classified these phages in new species clusters. Our study demonstrated the possibility to use infected body fluids as phage sources to isolate novel phages. GADU21 is the first reported Klebsiella phage isolated from human body fluid. The absence of virulence and antibiotic resistance genes in their genomes makes the phages a potential therapeutic tool against infections.


  • Open Access

    K fragment as a polymerase chain reaction-based vector for antibiotic resistance gene hunting

    by Hanife Salih Doğan, Erman Oryaşın, Bülent Bozdoğan

    AccScience Publishing is a publishing company based in Singapore. We have in our portfolio a range of high-quality, open-access, peer-reviewed journals and books from a broad spectrum of science, technology, biomedicine, engineering, education, social sciences and many more.

  • Open Access

    Environmental DNA transformation resulted in an active phage in Escherichia coli

    by Abdulkerim Karaynir, Bülent Bozdoğan, Hanife Salih Doğan

    The achievement of an active biological entity from environmental DNA is important in the field of phage. In this study, the environmental DNA extracted from hospital wastewater was transferred into Escherichia coli DH10B and Escherichia coli BL21 with chemical transformation and electroporation. After transformation, overnight cultures were filtered and used as phage source. The efficacies of the techniques were evaluated with spot test and double-layer agar assay. The emerged phage, named as ADUt, was purified and host-range analysis was performed. Phage DNA was isolated, sequenced and restriction profile was determined. The genome was assembled. The phylogenetic tree was constructed via VipTree. The extracted DNA resulted in active phage by the transformation of E. coli DH10B, but not E. coli BL21. The chemical transformation was found more successful than electroporation. ADUt phage was found to be polyvalent and effective against limited strains of Shigella and Escherichia genera. The phage genome size and GC ratio are 166904 bp and 35.67%, respectively. ADUt is a member of Straboviridae family and Tequatrovirus genus. This is the first study that uses environmental DNA for acquiring active phage, which may be an important source of new phage discovery. The result showed that DNA transformation yields active bacteriophage with both chemical transformation and electroporation.


  • Open Access

    Characterization, genome analysis and antibiofilm efficacy of lytic Proteus phages RP6 and RP7 isolated from university hospital sewage

    by Sahd Ali, Abdulkerim Karaynir, Hanife Salih, Serkan Öncü, Bülent Bozdoğan


  • Open Access

    K fragment, a PCR-based vector for antibiotic resistance gene hunting

    by Hanife Salih, Erman Oryaşın, Bülent Bozdoğan

    Antimicrobial resistance (AMR) is an important health issue in the world. To evaluate and predict, known and unknown resistance genes that are responsible for AMR should be identified and characterized. Unlike known genes, unknown genes are difficult to detect. In this study, we generated the plasmid of K fragment (pKF) from pUC19 vector by removing multiple cloning site (MCS) and adding Prom-RBS sequence. pKF was used for amplification of K fragment that contains RBS and promoter at both directions and plasmid origin of replication. The functionality of added Prom-RBS sequence and K fragment as a cloning vector was tested by cloning chloramphenicol resistance gene amplicon and erythromycin resistance gene from genomic DNA, respectively. Cloning of them confirmed the usability of this newly developed cloning method with K fragment. K fragment is a PCR based and antibiotic resistance gene-free cloning vector. It allows cloning of resistance genes at all orientations just by changing restriction enzymes for primers and fragmentation. This method enables the microbiological and molecular characterization of cloned genes. We expect the use of K fragment for cloning of resistance genes from different environments without cultivation. It will contribute to fighting AMR by identification of resistance genes before their dissemination.